期刊文献+

Survivin在结直肠癌中的表达及其临床意义 被引量:7

Expression of survivin and its clinical significance in colorectal carcinoma
下载PDF
导出
摘要 目的探讨结直肠癌组织中凋亡抑制因子survivin的表达及其与各临床病理因素的关系,评价survivin在结直肠癌预后判断中的价值。方法应用组织芯片结合免疫组织化学SABC法,检测126例早期结直肠癌组织中survivin的表达情况,回顾性分析survivin与各临床病理因素及预后之间的关系。结果根据免疫组化染色强度和分级结果,所有病例被分为survivin高表达组和低表达组。其中高表达组有26例(26/126,20.6%),低表达组有100例(100/126,79.4%)。survivin在结直肠癌中表达情况与年龄、性别、肿瘤大小、肿瘤部位、组织学类型、浸润深度、淋巴是否转移、Dukes分期均无显著相关。然而,高表达的survivin与肿瘤复发、特别是血行转移显著相关(P<0.05)。Survivin高表达组和低表达组的生存率用Kaplan-Meier方法评估,并用log-ranktest进行比较,两组之间生存率具有显著差异(P<0.05)。多因素分析结果显示,在潜在的预后因素中(年龄、性别、肿瘤大小、肿瘤部位、组织学类型、淋巴是否转移、Dukes分期、survivin表达),survivin表达和Dukes分期被认为是结直肠癌根治术后独立预后因素。结论Survivin的表达与结直肠癌的术后复发相关:结直肠癌术后复发率在survivin高表达组明显高于survivin低表达组,是与预后相关的独立危险因子。应用组织芯? Objective To investigate the relationship between the expression of survivin and the clincopathological factors of colorectal carcinoma and evaluate the significance of survivin in prognotic assessment of the patients. Methods Using tissue microarray and immunohistochemical method (SABC), we examined survivin expression in 126 patients with advanced colorectal cancer and retrospectively analyzed the relationship between survivin and both the clinicopathological features and prognosis of the malignancy. Result Of the 126 patients, 26 (21%) were found to have a high survivin expression and 100 (79%) had a low expression, without relation to the patients' age, gender, tumor size, tumor location, histological type, lymph node metastasis and Dukes' classification. High survivin expression was strongly correlated with tumor recurrence and especially with hematogenous metastasis (P<0.05). Kaplan-Meier method and log-rank test indicated significantly different disease-free survival rates between high- and low-survivin groups (P<0.05), and Dukes' stage and survivin expression of the tumor were identified in multivariate analysis as the independent significant factors related to disease-free survival. Conclusions Survivin expression in colorectal cancer has strong positive correlation with tumor recurrence as the independent risk factor related to prognosis. Tissue microarray enables rapid, convenient, economic and accurate large-scale examination of clinical specimens.
出处 《第一军医大学学报》 CSCD 北大核心 2004年第12期1412-1415,共4页 Journal of First Military Medical University
关键词 SURVIVIN 结直肠癌 组织芯片 预后 surviving colorectal cancer tissue microarray prognosis
  • 相关文献

参考文献2

二级参考文献47

  • 1Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genetics 2001; 10:657-662 被引量:1
  • 2Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P,Leighton S, Torhors J, Mihatsch MJ, Sauter G, Kalioniemi OP.Tissue microarray for high-throughput molecular profiling of tumor specimens. Nature Med 1998; 4:844-847 被引量:1
  • 3Moch H, Kononen T, Kallioniemi OP, Sauter G. Tissue microarray: what will they bring to molecular and anatomic pathology? Adv Anat Pathol 2001 ;8:14-20 被引量:1
  • 4Rimm DL, Camp RL, Charette LA, Costa J, Olsen DA, Reiss M.Tissue microarray: a new technology for amplification of tissue resources. CancerJ 2001 ;7:24-31 被引量:1
  • 5Nagle RB. New molecular approaches to tissue analysis. J Histochem Cytochem 2001 ;49:1063-1064 被引量:1
  • 6Bubendorf L, Nocito A, Moch H, Sauter G. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 2001; 195: 72-79 被引量:1
  • 7Yang GP, Ross DT, Kuang WW, Brown PO, Weigel RJ. Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res 1999 ;27:1517-1523 被引量:1
  • 8Wang K, Gan L, Jeffery E, Gayle M, Gown AM, Skelly M, Nelson PS, Ng WV, Schummer M, Hood L, Mulligan J. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 1999;229:101-108 被引量:1
  • 9Khan J, Saal LH, Bittner ML, Chen Y, Trent JM, Meltzer PS.Expression profiling in cancer using eDNA microarrays. Electrophoresis1999; 20: 223-229 被引量:1
  • 10Khan J, Simon R, Bittner N, Chen Y, Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM, Meltzer PS. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays.Cancer Res 1998 ;58:5009-5013 被引量:1

共引文献32

同被引文献50

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部